Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Hum Reprod ; 12(7): 435-42, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16735457

RESUMEN

Antiphospholipid syndrome (APS), characterized by circulating antiphospholipid (aPL) antibodies, is a major cause of early pregnancy failure and placental insufficiency. In this study, we examined whether impaired endometrial differentiation before conception contributes to the high incidence of pregnancy complications in APS. Timed secretory endometrial biopsies were obtained from a cohort of women with recurrent pregnancy loss (RPL). Real-time quantitative (RTQ)-PCR was used to determine the expression levels of transcripts that encode for decidual markers, proinflammatory cytokines and complement regulatory proteins. Expression of decidual markers such as prolactin (PRL), tissue factor (TF) and signal transducer and activator of transcription 5 (Stat5), but not insulin-like growth factor-binding protein 1 (IGFBP-1), was significantly lower in samples obtained from aPL(+) patients (n = 24) when compared with aPL(-) group (n = 58) (P < 0.05). The abundance of transcripts encoding for interferon gamma (IFNgamma), tumour necrosis factor alpha (TNFalpha) or Stat1 did not differ significantly between both groups (P >/= 0.05). However, analysis of transcripts that encode for complement regulatory proteins showed a marked decrease in decay-accelerating factor (DAF/CD55) levels in aPL(+) patients (P = 0.005), which was mimicked at protein level as demonstrated by immunohistochemistry. In summary, patients with RPL have distinct endometrial gene expression profiles depending on the presence or absence of circulating aPL antibodies. In APS, impaired endometrial differentiation and lower DAF/CD55 expression before conception may compromise implantation and predispose to complement-mediated pregnancy failure.


Asunto(s)
Aborto Habitual/genética , Antígenos de Diferenciación/genética , Síndrome Antifosfolípido/genética , Proteínas del Sistema Complemento/genética , Aborto Habitual/etiología , Aborto Habitual/patología , Adulto , Anticuerpos Antifosfolípidos/farmacología , Síndrome Antifosfolípido/complicaciones , Antígenos CD55/genética , Antígenos CD55/metabolismo , Antígenos CD59/genética , Estudios de Casos y Controles , Endometrio/efectos de los fármacos , Endometrio/metabolismo , Femenino , Expresión Génica/efectos de los fármacos , Expresión Génica/genética , Humanos , Inmunohistoquímica/métodos , Proteína 1 de Unión a Factor de Crecimiento Similar a la Insulina/genética , Interferón gamma/genética , Proteína Cofactora de Membrana/genética , Embarazo , Prolactina/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Tromboplastina/genética , Factor de Necrosis Tumoral alfa/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA